Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

miR-129-3p inhibits NHEJ pathway by targeting SAE1 and represses gastric cancer progression.

Zhang M, Jiang D, Xie X, He Y, Lv M, Jiang X.

Int J Clin Exp Pathol. 2019 May 1;12(5):1539-1547. eCollection 2019.

2.

Safety and efficacy of coblopasvir and sofosbuvir in patients with genotypes 1, 2, 3 and 6 HCV infections without or with compensated cirrhosis.

Rao H, Song G, Li G, Yang Y, Wu X, Guan Y, Mao Q, Jiang X, Wang C, Zhang Y, Jia J, Guo X, Li C, Ning J, Qin H, Pan H, Wei L.

J Viral Hepat. 2020 Jan;27(1):45-51. doi: 10.1111/jvh.13208. Epub 2019 Oct 2.

PMID:
31520460
3.

Active Adjustment of Surface Accuracy for a Large Cable-Net Structure by Shape Memory Alloy.

Jiang X, Pan F, Fan Y, Du J, Zhu M, Chen Z.

Materials (Basel). 2019 Aug 16;12(16). pii: E2619. doi: 10.3390/ma12162619.

4.

Vinculin promotes gastric cancer proliferation and migration and predicts poor prognosis in patients with gastric cancer.

Zhang M, Liu P, Xu F, He Y, Xie X, Jiang X.

J Cell Biochem. 2019 Aug;120(8):14107-14115. doi: 10.1002/jcb.28686. Epub 2019 Apr 15.

PMID:
30989694
5.

Finite Element Analysis for the Self-Loosening Behavior of the Bolted Joint with a Superelastic Shape Memory Alloy.

Jiang X, Huang J, Wang Y, Li B, Du J, Hao P.

Materials (Basel). 2018 Sep 2;11(9). pii: E1592. doi: 10.3390/ma11091592.

6.

Knockdown of long non-coding RNA ANRIL inhibits tumorigenesis in human gastric cancer cells via microRNA-99a-mediated down-regulation of BMI1.

Liu P, Zhang M, Niu Q, Zhang F, Yang Y, Jiang X.

Braz J Med Biol Res. 2018 Aug 16;51(10):e6839. doi: 10.1590/1414-431X20186839.

7.

The additive effects of the TM6SF2 E167K and PNPLA3 I148M polymorphisms on lipid metabolism.

Chen L, Du S, Lu L, Lin Z, Jin W, Hu D, Jiang X, Xin Y, Xuan S.

Oncotarget. 2017 Jun 14;8(43):74209-74216. doi: 10.18632/oncotarget.18474. eCollection 2017 Sep 26.

8.

[Role and mechanism of action of fibroblast growth factor-21 in reducing triglyceride in nonalcoholic fatty liver disease].

Chen L, Jiang M, Xin Y, Wang J, Liu Y, Jiang X, Xuan S.

Zhonghua Gan Zang Bing Za Zhi. 2016 Feb;24(2):102-7. doi: 10.3760/cma.j.issn.1007-3418.2016.02.006. Chinese.

PMID:
26983476
9.

Genetic Variants in the SAMM50 Gene Create Susceptibility to Nonalcoholic Fatty Liver Disease in a Chinese Han Population.

Chen L, Lin Z, Jiang M, Lu L, Zhang H, Xin Y, Jiang X, Xuan S.

Hepat Mon. 2015 Oct 10;15(10):e31076. doi: 10.5812/hepatmon.31076. eCollection 2015 Oct.

10.

[Role of SREBP-1c in risk of liver disease associated with the triacylglycerol lipase PNPLA3 I148M variant].

Huang H, An B, Xin Y, Jiang M, Jin W, Lin Z, Jiang X, Xuan S.

Zhonghua Gan Zang Bing Za Zhi. 2015 Oct;23(10):771-4. doi: 10.3760/cma.j.issn.1007-3418.2015.10.012. Chinese.

PMID:
26573195
11.

[Association between APOC3 promoter region polymorphisms and non-alcoholic fatty liver disease].

Niu T, Jiang M, Liu H, Jiang X, Lin Z, Zhang M, Wang J, Geng N, Xin Y, Xuan S.

Zhonghua Gan Zang Bing Za Zhi. 2014 May;22(5):374-9. doi: 10.3760/cma.j.issn.1007-3418.2014.05.011. Chinese.

PMID:
25180874
12.

[Association between the PNPLA3 I148M polymorphism and chronic hepatitis B in a Qingdao Han Chinese population].

Jiang M, Xin Y, Wang W, Lin Z, Zhang D, Li C, Jiang X, Xuan S.

Zhonghua Gan Zang Bing Za Zhi. 2014 May;22(5):340-3. doi: 10.3760/cma.j.issn.1007-3418.2014.05.004. Chinese.

PMID:
25180867
13.

A dynamic attitude measurement system based on LINS.

Li H, Pan Q, Wang X, Zhang J, Li J, Jiang X.

Sensors (Basel). 2014 Aug 29;14(9):16082-108. doi: 10.3390/s140916082.

14.

Molecular dynamics simulation of PNPLA3 I148M polymorphism reveals reduced substrate access to the catalytic cavity.

Xin YN, Zhao Y, Lin ZH, Jiang X, Xuan SY, Huang J.

Proteins. 2013 Mar;81(3):406-14. doi: 10.1002/prot.24199. Epub 2012 Nov 5.

PMID:
23042597
15.

Diagnostic accuracy of the aspartate aminotransferase-to-platelet ratio index for the prediction of hepatitis B-related fibrosis: a leading meta-analysis.

Jin W, Lin Z, Xin Y, Jiang X, Dong Q, Xuan S.

BMC Gastroenterol. 2012 Feb 14;12:14. doi: 10.1186/1471-230X-12-14. Review.

16.

Discovery of matrix metalloproteases selective and activated peptide-doxorubicin prodrugs as anti-tumor agents.

Hu Z, Jiang X, Albright CF, Graciani N, Yue E, Zhang M, Zhang SY, Bruckner R, Diamond M, Dowling R, Rafalski M, Yeleswaram S, Trainor GL, Seitz SP, Han W.

Bioorg Med Chem Lett. 2010 Feb 1;20(3):853-6. doi: 10.1016/j.bmcl.2009.12.084. Epub 2010 Jan 4.

PMID:
20060717
17.

Investigation of glycine alpha-ketoamide HCV NS3 protease inhibitors: effect of carboxylic acid isosteres.

Han W, Jiang X, Hu Z, Wasserman ZR, Decicco CP.

Bioorg Med Chem Lett. 2005 Aug 1;15(15):3487-90.

PMID:
15982872
18.

Glycine alpha-ketoamides as HCV NS3 protease inhibitors.

Han W, Hu Z, Jiang X, Wasserman ZR, Decicco CP.

Bioorg Med Chem Lett. 2003 Mar 24;13(6):1111-4.

PMID:
12643923

Supplemental Content

Loading ...
Support Center